Investigating Sources of Heterogeneity in Randomized Controlled Trials of the Effects of Pharmacist Interventions on Glycemic Control in Type 2 Diabetic Patients: A Systematic Review and Meta-Analysis

Abstract

ObjectiveTo assess the effect of pharmacist interventions on glycemic control in type 2 diabetic patients and to examine factors that could explain the variation across studies.MethodsA comprehensive literature search was performed in PubMed, Scopus, and LILACS databases for randomized controlled trials (RCTs) published up to July 2015. The search strategy included the use of MeSH terms or text words related to pharmacist interventions, type 2 diabetes, and randomized controlled trials. RCTs published in English, Portuguese, or Spanish that evaluated the effect of pharmacist intervention on glycemic control in type 2 diabetic outpatients were included. Two independent authors executed study selection, data extraction, and risk of bias assessment. Mean differences in glycosylated hemoglobin (HbA1c) were estimated using random-effect models, and heterogeneity was evaluated by subgroup and meta-regression analyses.ResultsThe literature search yielded 963 records of potential interest, of which 30 were included in the systematic review and 22 in the meta-analysis. Most of these RCTs were conducted in the United States in patients in outpatient clinics using face-to-face contact only. All RCTs performed patient education, and most executed the medication review. The appraised sample showed uncertain or high risk of bias in most of the items evaluated, resulting in low-quality studies. In comparison with usual care, pharmacist interventions were associated with significant reductions in HbA1c levels (-8.5% [95% CI: -1.06, -0.65]; P < 0.0001; I2 = 67.3%). Subgroup analysis indicated differences of heterogeneity by country, baseline HbA1c levels, setting, intervention frequency, and random allocation. Age and HbA1c levels partly explained the variability across studies by meta-regression.ConclusionsOur findings confirmed that pharmacist interventions improve glycemic control in patients with type 2 diabetes compared with usual care and suggest that younger patients or with higher baseline HbA1c levels may be the main beneficiaries of pharmacist care.Protocol PROSPERO Registration NumberCRD42014007457

Pharmacist–physician collaborative care model for patients with uncontrolled type 2 diabetes in Brazil: results from a randomized controlled trial

“…These meta‐analyses included different practice settings, severity of disease and components of pharmacist interventions; then, we believe that there may be an effect size difference compared with our diabetes outpatient clinic. In addition, a multiple regression analysis indicated that our pharmacist‐physician collaborative care model was more effective for patients with poor glycemic control, which is similar to findings of recent meta‐analysis on pharmacist interventions for patients with diabetes .…”

“…Randomized controlled trials have shown a positive impact of interventions delivered by pharmacists in collaboration with physicians on glycemic control in outpatients with type 2 diabetes . However, most clinical trials were carried out in developed countries and interventions and study design were poorly described ; this may hamper the implementation of the conducted clinical pharmacy services into others realities, the mapping the components of the pharmacist interventions and measure their actual effects. Besides, studies on pharmacist interventions have focused primarily on outcomes reporting and usually do not provide useful insights into factors that make an intervention successful in achieving outcomes .…”

Pharmacist‐led discharge medication counselling: A scoping review

“…High heterogeneity values negatively contribute to the strength of the evidence . Investigating the sources of heterogeneity is a prerequisite to demonstrating the impact of pharmacists' interventions . Several attempts were made to enhance the quality of the description of the components of pharmacists' interventions …”

The Effectiveness of Pharmacological and Non-Pharmacological Interventions for Improving Glycaemic Control in Adults with Severe Mental Illness: A Systematic Review and Meta-Analysis

“…Also, combining pharmacological and behavioural strategies may incrementally (or perhaps even synergistically) increase effectiveness [34]. However, the effect sizes observed were modest when compared to the general population [18, 78], suggesting that tailored interventions which address the specific challenges faced by people with SMI are needed.…”

“…We also conducted univariate random effects meta-regression using mean HbA 1c or fasting glucose at baseline to explore whether or not this explained some of the heterogeneity among studies [18]. …”